HLB Genex, Inc. (KOSDAQ:187420)

Market Cap	79.82B -11.5%
Revenue (ttm)	45.67B +14.4%
Net Income	9.26B
EPS	310.38
Shares Out	32.64M
PE Ratio	7.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	272,217
Open	2,370.00
Previous Close	2,360.00
Day's Range	2,245.00 - 2,445.00
52-Week Range	1,323.00 - 3,680.00
Beta	0.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About HLB Genex

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2. The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, o...

• Industry: Industrial Organic Chemicals
• Founded: 2000
• Employees: 75
• Stock Exchange: KOSDAQ
• Ticker Symbol: 187420

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 2, 2026

Data Sources Report a data error